The Journal of Pediatrics
Volume 153, Issue 5 , Pages 599-604.e2 , November 2008

Medicines for Children: A Matter of Taste

  • Elin Haf Davies, RN (Child) BSc (Hons), MSc

      Affiliations

    • Medicines for Children SENCE Local Research Network, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom
    • ,
  • Catherine Tuleu, PhD, MSc(DEA), Docteur en Pharmacie, Cert Ed, MRPharmS

      Affiliations

    • Department of Pharmaceutics and Centre for Paediatric Pharmacy Research, The School of Pharmacy, University of London, London, United Kingdom
    • Corresponding Author InformationReprints are not available. Corresponding author is Dr. Catherine Tuleu, 29-39 Brunswick Square, London WC1N 1AX UK

Received 28 February 2008 ,Revised 29 April 2008 ,Accepted 18 June 2008.

References 

  1. Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/reg_2006_1901/reg_2006_1901_en.pdfAccessed April 28, 2008
  2. CHMP EMEA Reflection paper: Formulation of choice for the paediatric population. http://www.emea.europa.eu/pdfs/human/paediatrics/19481005en.pdfAccessed April 28, 2008
  3. Matsui D. Assessing the palatability of medication in children. Paediatr Perinat Drug Ther. 2007;8:55–60
  4. Oram N, Laing DG, Hutchinson I, Owen J, Rose G, Freeman M, et al. The influence of flavor and color on drink identification by children and adults. Dev Psychobiol. 1995;28:239–246
  5. Duffy VB. Variation in oral sensation: implications for diet and health. Curr Opin Gastroenterol. 2007;23:171–177
  6. Leopold DA, Bartoshuk L, Doty RL, Jafek B, Smith DV, Snow JB. Aging of the upper airway and the senses of taste and smell. Otolaryngol Head Neck Surg. 1989;100:287–289
  7. Doty RL, Frye R. Influence of nasal obstruction on smell function. Otolaryngol Clin North Am. 1989;22:397–411
  8. Doty RL, Shah M, Bromley SM. Drug-induced taste disorders. Drug Saf. 2008;31:199–215
  9. Doty L. Gender and reproductive state correlates of taste perception in human. In:  McGill TE editors. Sex and Behavior: Status and Prospectus. New York, NY: Plenum Press NYC; 1978;p. 337–362
  10. Standing JF, Tuleu C. Paediatric formulations: getting to the heart of the problem. Int J Pharm. 2005;300:56–66
  11. Liem DG, Mennella JA. Heightened sour preferences during childhood. Chem Senses. 2003;28:173–180
  12. te Loo DM, van der Graaf F, Ten WT. The effect of flavoring oral rehydration solution on its composition and palatability. J Pediatr Gastroenterol Nutr. 2004;39:545–548
  13. Gabriels M, Plaizier-Vercammen J. Experimental designed optimisation and stability evaluation of dry suspensions with artemisinin derivatives for paediatric use. Int J Pharm. 2004;283:19–34
  14. Van Arendonk KJ, Knudson MJ, Austin JC, Cooper CS. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin. Urology. 2006;68:862–865
  15. Bunupuradah T, Wannachai S, Chuamchaitrakool A, Intasan J, Nuchapong T, Neiss W, et al. Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals. AIDS Res Ther. 2006;3:30
  16. Gooch WM, Philips A, Rhoades R, Rosenberg R, Schaten R, Starobin S. Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media. Pediatr Infect Dis J. 1997;16(Suppl 2):S21–S24
  17. Steele RW, Thomas MP, Begue RE, Despinasse BP. Selection of pediatric antibiotic suspensions: taste and cost factors. Infect Med. 1999;16:197–200
  18. Holas C, Chiu YL, Notario G, Kapral D. A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years. Clin Ther. 2005;27:1950–1960
  19. Powers JL, Gooch WM, Oddo LP. Comparison of the palatability of the oral suspension of cefdinir vs amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. Pediatr Infect Dis J. 2000;19(Suppl 12):S174–S180
  20. Uhari M, Eskelinen L, Jokisalo J. Acceptance of antibiotic mixtures by infants and children. Eur J Clin Pharmacol. 1986;30:503–504
  21. Kim MK, Yen K, Redman RL, Nelson TJ, Brandos J, Hennes HM. Vomiting of liquid corticosteroids in children with asthma. Pediatr Emerg Care. 2006;22:397–401
  22. Almenrader N, Passariello M, Coccetti B, Haiberger R, Pietropaoli P. Steal-induction after clonidine premedication: a comparison of the oral and nasal route. Paediatr Anaesth. 2007;17:230–234
  23. Martinez JM, Bartoli F, Recaldini E, Lavanchy L, Bianchetti MG. A taste comparison of two different liquid cholecalciferol (vitamin D3) preparations in healthy newborns and infants. Clin Drug Investig. 2006;26:663–665
  24. Cheng A, Ratnapalan S. Improving the palatability of activated charcoal in pediatric patients. Pediatr Emerg Care. 2007;23:384–386
  25. Reader S, Shaw H. A taste-testing study in healthy volunteers (children) to investigate children's preference for ibuprofen or placebo suspension. S. SH. Paediatr Perinat Drug Ther. 2006;7:54–58
  26. Cohen IT, Joffe D, Hummer K, Soluri A. Ondansetron oral disintegrating tablets: acceptability and efficacy in children undergoing adenotonsillectomy. Anesth Analg. 2005;101:59–63
  27. Dagnone D, Matsui D, Rieder MJ. Assessment of the palatability of vehicles for activated charcoal in pediatric volunteers. Pediatr Emerg Care. 2002;18:19–21
  28. Skokan EG, Junkins EP, Corneli HM, Schunk JE. Taste test: children rate flavoring agents used with activated charcoal. Arch Pediatr Adolesc Med. 2001;155:683–686
  29. Meier CM, Simonetti GD, Ghiglia S, Fossali E, Salice P, Limoni C, et al. Palatability of angiotensin II antagonists among nephropathic children. Br J Clin Pharmacol. 2007;63:628–631
  30. Lucas-Bouwman ME, Roorda RJ, Jansman FG, Brand PL. Crushed prednisolone tablets or oral solution for acute asthma?. Arch Dis Child. 2001;84:347–348
  31. Ameen VZ, Pobiner BF, Giguere GC, Carter EG. Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study. Paediatr Drugs. 2006;8:265–270
  32. Nasrin D, Larson CP, Sultana S, Khan TU. Acceptability of and adherence to dispersible zinc tablet in the treatment of acute childhood diarrhoea. J Health Popul Nutr. 2005;23:215–221
  33. Tolia V, Han C, North JD, Amer F. Taste comparisons for Lansoprazole strawberry-flavoured delayed-release orally disintegrating tablet and ranitidine peppermint-flavoured syrup in children. Clin Drug Investig. 2005;25:285–292
  34. Motte J, Pedespan JM, Sevestre M, Chiron C. Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old. Arch Pediatr. 2005;12:1533–1539
  35. Tolia V, Johnston G, Stolle J, Lee C. Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years. Paediatr Drugs. 2004;6:127–131
  36. Bagger-Sjoback D, Bondesson G. Taste evaluation and compliance of two paediatric formulations of phenoxymethylpenicillin in children. Scand J Prim Health Care. 1989;7:87–92
  37. Sjovall J, Fogh A, Huitfeldt B, Karlsson G, Nylen O. Methods for evaluating the taste of paediatric formulations in children: a comparison between the facial hedonic method and the patients' own spontaneous verbal judgement. Eur J Pediatr. 1984;141:243–247
  38. Toscani M, Drehobl M, Freed J, Stool S. A multicenter, randomized, comparative assessment in healthy pediatric volunteers of the palatability of oral antibiotics effective in the therapy of otitis media. Curr Ther Res Clin Exp. 2000;61:278–285
  39. Angelili ML, Toscani M, Matsui DM, Rieder M. Palatability of oral antibiotics among children in an urban primary care center. Arch Pediatr Adolesc Med. 2000;154:267–270
  40. Matsui D, Lim R, Tschen T, Rieder MJ. Assessment of the palatability of beta-lactamase-resistant antibiotics in children. Arch Pediatr Adolesc Med. 1997;151:599–602
  41. Matsui D, Barron A, Rieder MJ. Assessment of the palatability of antistaphylococcal antibiotics in pediatric volunteers. Ann Pharmacother. 1996;30:586–588
  42. El-Chaar GM, Mardy G, Wehlou K, Rubin LG. Randomized, double blind comparison of brand and generic antibiotic suspensions, II: a study of taste and compliance in children. Pediatr Infect Dis J. 1996;15:18–22
  43. Dagan R, Shvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J. 1994;13:686–690
  44. Jahnsen T, Thorn P. An acceptability study of two pivampicillin mixtures in children in general practice. Scand J Prim Health Care. 1987;5:241–243
  45. Berg J, Riedy CA, Tercero A. Patient and parental perception of a new fluoride varnish. Compend Contin Educ Dent. 2006;27:614–618
  46. James CE, Laing DG, Oram N. A comparison of the ability of 8-9-year-old children and adults to detect taste stimuli. Physiol Behav. 1997;62:193–197
  47. James CE, Laing DG, Oram N, Hutchinson I. Perception of sweetness in simple and complex taste stimuli by adults and children. Chem Senses. 1999;24:281–287
  48. Mennella JA, Pepino MY, Reed DR. Genetic and environmental determinants of bitter perception and sweet preferences. Pediatrics. 2005;115:e216–e222
  49. Davies EH, Molloy A. Comparison of ethyl chloride spray with topical anaesthetic in children experiencing venepuncture. Paediatr Nurs. 2006;18:39–43

 The authors declare no conflicts of interest.

PII: S0022-3476(08)00529-5

doi: 10.1016/j.jpeds.2008.06.030

The Journal of Pediatrics
Volume 153, Issue 5 , Pages 599-604.e2 , November 2008

Article Tools